Cardinal Health (NYSE:CAH) Stock Rating Lowered by TheStreet

Cardinal Health (NYSE:CAH) was downgraded by equities researchers at TheStreet from a “c+” rating to a “d” rating in a note issued to investors on Thursday, TheStreetRatingsTable reports.

Several other analysts have also issued reports on CAH. Argus lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, August 27th. ValuEngine upgraded shares of Cardinal Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 2nd. Deutsche Bank initiated coverage on shares of Cardinal Health in a research report on Thursday, September 12th. They issued a “hold” rating and a $50.00 price target on the stock. Morgan Stanley decreased their price target on shares of Cardinal Health from $50.00 to $41.00 and set an “underweight” rating on the stock in a research report on Friday, September 6th. Finally, Guggenheim set a $55.00 price target on shares of Cardinal Health and gave the stock a “buy” rating in a research report on Thursday, September 12th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. Cardinal Health currently has an average rating of “Hold” and an average target price of $53.50.

CAH traded up $0.55 during trading on Thursday, hitting $53.75. The stock had a trading volume of 3,313,580 shares, compared to its average volume of 2,953,817. The firm has a market cap of $15.06 billion, a PE ratio of 10.18, a P/E/G ratio of 1.72 and a beta of 1.32. Cardinal Health has a 12 month low of $41.03 and a 12 month high of $58.31. The company has a current ratio of 1.07, a quick ratio of 0.54 and a debt-to-equity ratio of 1.20. The company has a 50 day simple moving average of $48.75 and a 200-day simple moving average of $46.39.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, November 7th. The company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.09 by $0.18. The firm had revenue of $37.34 billion for the quarter, compared to the consensus estimate of $36.75 billion. Cardinal Health had a net margin of 0.94% and a return on equity of 25.96%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.29 EPS. As a group, sell-side analysts anticipate that Cardinal Health will post 4.99 earnings per share for the current fiscal year.

Institutional investors have recently modified their holdings of the company. MML Investors Services LLC boosted its position in Cardinal Health by 1.2% in the second quarter. MML Investors Services LLC now owns 19,478 shares of the company’s stock valued at $917,000 after buying an additional 225 shares in the last quarter. Rockland Trust Co. boosted its position in Cardinal Health by 1.4% in the second quarter. Rockland Trust Co. now owns 16,807 shares of the company’s stock valued at $792,000 after buying an additional 231 shares in the last quarter. Exeter Financial LLC boosted its position in Cardinal Health by 1.5% in the third quarter. Exeter Financial LLC now owns 15,820 shares of the company’s stock valued at $747,000 after buying an additional 236 shares in the last quarter. First Allied Advisory Services Inc. boosted its position in Cardinal Health by 2.2% in the third quarter. First Allied Advisory Services Inc. now owns 11,759 shares of the company’s stock valued at $555,000 after buying an additional 248 shares in the last quarter. Finally, Securian Asset Management Inc boosted its position in Cardinal Health by 0.9% in the second quarter. Securian Asset Management Inc now owns 30,656 shares of the company’s stock valued at $1,444,000 after buying an additional 265 shares in the last quarter. Institutional investors and hedge funds own 90.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

See Also: Resistance Level

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.